Internal Medicine
Case
A 62-year-old man with type 2 diabetes mellitus and a myocardial infarction 18 months ago is seen in the cardiology outpatient clinic of an IMSS hospital. He reports dyspnea climbing one flight of stairs and two-pillow orthopnea for 6 months. He takes enalapril 10 mg twice daily, carvedilol 12.5 mg twice daily and dapagliflozin 10 mg daily, with good adherence. Examination: BP 124/76 mmHg, HR 68 bpm, no jugular venous distension or edema. Labs: potassium 4.4 mEq/L, creatinine 1.0 mg/dL (estimated glomerular filtration rate 82 mL/min/1.73 m²). Echocardiogram 4 months ago: left ventricular ejection fraction (LVEF) 28 %, dilated LV, no significant valve disease.
Question 1
Which drug should be added to reduce mortality and heart failure hospitalizations?
- Digoxin
- Spironolactone
- Amlodipine
- Extended-release diltiazem
Show answer and explanation
Correct answer: B. Spironolactone
Foundational therapy for HF with reduced EF has four pillars: ACE inhibitor/ARB/ARNI, beta-blocker, mineralocorticoid receptor antagonist and SGLT2 inhibitor. He already takes three; the missing one is the mineralocorticoid antagonist, used when potassium is <5.0 mEq/L and eGFR >30 mL/min.
Question 2
After 3 months of optimal medical therapy, LVEF remains 28 % and life expectancy exceeds one year. Which intervention is indicated to prevent sudden death?
- Atrioventricular node ablation with pacemaker implantation
- Indefinite oral amiodarone
- Implantable cardioverter-defibrillator (ICD) implantation
- Routine surgical revascularization
Show answer and explanation
Correct answer: C. Implantable cardioverter-defibrillator (ICD) implantation
Arrhythmic sudden death is a common cause of death with reduced EF. If after at least 3 months of optimal therapy LVEF stays ≤35 % and expected survival exceeds one year, an ICD improves survival. With a wide QRS, resynchronization is also considered.
References:AHA/ACC/HFSA-2022 (2022)
